CADASIL is a rare genetic disorder with no cure. The condition is best managed by an interprofessional team that includes pharmacists, nurses and geneticists. It often causes ischemia but in the absence of atherosclerosis. The key is to reverse the modifable risk factors for heart and stroke disease. Most patients are treated symptomatically.

The overall outcome for patients with CADASIL is guarded and life expectacy is reduced. Once dignosed, genetic counseling should be offered to patients diagnosed with CADASIL.